Electrophysiological interactions between haloperidol and reduced haloperidol, and dopamine, norepinephrine and phencyclidine in rat brain
- PMID: 2862598
- DOI: 10.1016/0028-3908(85)90021-8
Electrophysiological interactions between haloperidol and reduced haloperidol, and dopamine, norepinephrine and phencyclidine in rat brain
Abstract
Haloperidol and its metabolite, reduced haloperidol, were compared as antagonists of catecholaminergic neurotransmission in central nervous system of the rat. Agonists and antagonists were applied from multibarrelled micropipettes, which were also used to record extracellularly the effects of these substances on neuronal discharge. Haloperidol antagonized dopaminergic inhibition of caudate neurons and inhibition of cerebellar Purkinje neurons induced by noradrenaline, whereas reduced haloperidol was an ineffective antagonist. Phencyclidine, which is an indirect dopaminergic agonist in the caudate, caused inhibition of the discharges of caudate neurons resembling that induced by dopamine itself. These indirect effects of phencyclidine were also antagonized by haloperidol but not by reduced haloperidol. The data suggest that the metabolite, reduced haloperidol, is not an effective neuroleptic drug in the central nervous system.
Similar articles
-
Investigation of the failure of parenterally administered haloperidol to antagonize dopamine released from micropipettes in the caudate.J Neurosci. 1986 Feb;6(2):572-80. doi: 10.1523/JNEUROSCI.06-02-00572.1986. J Neurosci. 1986. PMID: 3081693 Free PMC article.
-
Candidate mechanisms underlying phencyclidine-induced psychosis: an electrophysiological behavioral, and biochemical study.Biol Psychiatry. 1982 Feb;17(2):155-98. Biol Psychiatry. 1982. PMID: 6122473
-
Electrophysiological effects of phencyclidine and the sigma agonist ditolylguanidine in the cerebellum of the rat.Neuropharmacology. 1992 Jan;31(1):77-83. doi: 10.1016/0028-3908(92)90164-k. Neuropharmacology. 1992. PMID: 1311809
-
A role for noradrenergic transmission in the actions of phencyclidine and the antipsychotic and antistress effects of mGlu2/3 receptor agonists.Ann N Y Acad Sci. 2003 Nov;1003:309-17. doi: 10.1196/annals.1300.019. Ann N Y Acad Sci. 2003. PMID: 14684454 Review.
-
Influence of long-lasting administration of neuroleptics on cortical NMDA receptors and phencyclidine-induced deficit in the sensorimotor gating in rats.Pol J Pharmacol. 1999 Jan-Feb;51(1):49-53. Pol J Pharmacol. 1999. PMID: 10389144 Review.
Cited by
-
Pharmacokinetics of haloperidol.Clin Pharmacokinet. 1989 Dec;17(6):396-423. doi: 10.2165/00003088-198917060-00004. Clin Pharmacokinet. 1989. PMID: 2689040 Review.
-
The relationship between serum concentration and therapeutic effect of haloperidol in patients with acute schizophrenia.Clin Pharmacokinet. 1998 Mar;34(3):227-63. doi: 10.2165/00003088-199834030-00005. Clin Pharmacokinet. 1998. PMID: 9533984 Review.
-
Interconversion between haloperidol and reduced haloperidol in healthy volunteers.Eur J Clin Pharmacol. 1989;37(1):45-8. doi: 10.1007/BF00609423. Eur J Clin Pharmacol. 1989. PMID: 2591462
-
The measurement of haloperidol and reduced haloperidol in hair as an index of dosage history.Br J Clin Pharmacol. 1990 Feb;29(2):187-94. doi: 10.1111/j.1365-2125.1990.tb03618.x. Br J Clin Pharmacol. 1990. PMID: 2306410 Free PMC article.
-
Reduced haloperidol plasma concentration and clinical response in acute exacerbations of schizophrenia.Psychopharmacology (Berl). 1990;102(4):514-20. doi: 10.1007/BF02247134. Psychopharmacology (Berl). 1990. PMID: 2096408